Literature DB >> 26424308

Pulmonary Sarcoidosis Presenting with Miliary Opacities.

Masato Taki1, Naoya Ikegami, Chisato Konishi, Satoshi Nakao, Tomoko Funazou, Ryo Ariyasu, Masanori Yoshida, Kazuhiko Nakagawa, Kyouhei Morita, Moon Hee Hwang, Chie Yoshimura, Toshiaki Wakayama, Yasuo Nishizaka.   

Abstract

Lung lesions often appear in patients with sarcoidosis; however, miliary opacities are rare. We herein report the case of a 40-year-old woman with pulmonary sarcoidosis who presented with dyspnea on exertion. Subsequent computed tomography showed miliary opacities, and the presence of granulomas was confirmed by a transbronchial lung biopsy. Glucocorticoid therapy was initiated and the symptoms and miliary opacities rapidly improved. Although miliary sarcoidosis is uncommon, physicians should consider sarcoidosis in addition to tuberculosis, malignancy, and pneumoconiosis when presented with miliary opacities.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26424308     DOI: 10.2169/internalmedicine.54.4681

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Miliary Sarcoidosis: does it exist? A case series and systematic review of literature.

Authors:  Srinivas Rajagopala; Sakthi Sankari; Roopa Kancherla; Ramanathan Palaniappan Ramanathan; Devanand Balalakshmoji
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-15       Impact factor: 0.670

2.  Miliary opacities in pulmonary sarcoidosis.

Authors:  Keishi Sugino; Hirotaka Ono; Masahiro Ando; Seiji Igarashi; Atsuko Kurosaki; Eiyasu Tsuboi
Journal:  Respirol Case Rep       Date:  2020-04-18

3.  Seeds in the Lungs: A Pseudo-Miliary Pattern of Sarcoidosis.

Authors:  Subrat Khanal; Sindhubarathi Murali; Pranita Ghimire; Andrew Chu
Journal:  Cureus       Date:  2022-01-24

4.  Diffuse Lung Metastases in EGFR-Mutant Non-Small Cell Lung Cancer.

Authors:  Subba R Digumarthy; Dexter P Mendoza; Atul Padole; Tianqi Chen; P Gabriel Peterson; Zofia Piotrowska; Lecia V Sequist
Journal:  Cancers (Basel)       Date:  2019-09-13       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.